An Alzheimer’s drug that is being developed by Biogen and Eisai is showing some positive results. The newly developed drug that is currently in a phase three trial showed that the experimental monoclonal antibody reduced cognitive decline...
(NAPSI)—If you’re like many people, you may be curious about crypto. From crypto direct deposits and debit cards to decentralized saving and lending and cross-border payments, the cryptoeconomy is rapidly challenging many of the core ideas around...
Rare disease therapy developer, Immusoft, has signed a licensing agreement with Takeda Pharmaceutical with a total potential value of more than $900 million, to discover, develop and commercialize transformative cell therapies in rare inherited metabolic disorders with...
Krispy Kreme begins trading under "DNUT" on the Nasdaq Global Select Market on Thursday, offering 29 million shares of its common stock at a public offering price of $17 per share — coming in far below industry estimates.
While the fashion industry reckons with female body image positivity, investors embraced plus-size retailer Torrid in its Wall Street debut Thursday.
Torrid, an apparel company for women who wear sizes 10 to 30, shares...
According to Lincoln Financial Group’s Monthly Consumer Sentiment Tracker, Asian Americans (37%) are most worried about lost income from layoffs and reduced employment hours as a result of COVID-19—a fear that is not unfounded in a population hit...
India is reportedly moving forward with a sweeping ban on cryptocurrencies. According to media reports, the country’s legislature will introduce a bill that criminalizes trading, mining, issuing, transferring, or possessing cryptocurrency. The bill is likely to pass if...
IronNet Cybersecurity announced on Monday that it will go public through a combination with LGL Systems Acquisition. The company leads a list of new SPAC IPO's.
Shares of Seneca Biopharma (NASDAQ:SNCA) are very active pre-market following their run Friday. While $SNCA stock closed at $1.64 during the regular session, shares climbed as high as $1.93 before the final...
Pfizer has announced the U.S. Food and Drug Administration (FDA) has approved ZAVZPRET™ (zavegepant), the first and only calcitonin gene-related peptide (CGRP)...
